![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Kirchheiner Julia Roots Ivar Goldammer Mark Rosenkranz Bernd
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.44, Iss.12, 2005-01, pp. : 1209-1225
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Pan Yan Tiong Kai Abd-Rashid Badrul Ismail Zakiah Ismail Rusli Mak Joon Ong Chin
Journal of Natural Medicines, Vol. 68, Iss. 2, 2014-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Drug Investigation, Vol. 27, Iss. 4, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Effect of CYP2C9 polymorphisms on pharmacokinetics of nateglinide
Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Holstein Andreas Beil Winfried Kovacs Peter
Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. :